IFNG and cancer: T cells recognizing cancer antigens on MHC class I release interferon-γ (IFN-γ), which in response activates the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway, and induces PD-L1 expression on the cancer-cell surface.